AKR1C3 expression in T acute lymphoblastic leukemia/lymphoma for clinical use as a biomarker

To investigate aldo–keto reductase 1C3 (AKR1C3) expression in T and B acute lymphoblastic leukemia/lymphoma (ALL) patients. Three commercial antibodies were evaluated for AKR1C3 immunohistochemistry (IHC) staining performance: Polyclonal Thermofisher scientific (Clone#PA523667), rabbit monoclonal Ab...

Descripción completa

Detalles Bibliográficos
Autores principales: Reddi, Deepti, Seaton, Brandon W., Woolston, David, Aicher, Lauri, Monroe, Luke D., Mao, Zhengwei J., Harrell, Jill C., Radich, Jerald P., Advani, Anjali, Papadantonakis, Nikolaos, Yeung, Cecilia C. S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986791/
https://www.ncbi.nlm.nih.gov/pubmed/35388063
http://dx.doi.org/10.1038/s41598-022-09697-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986791/
https://www.ncbi.nlm.nih.gov/pubmed/35388063
http://dx.doi.org/10.1038/s41598-022-09697-6

Ejemplares similares